MedPath

Effect of Morus Alba leaves’s extract supplement on type 2 diabetes

Phase 3
Conditions
Diabets type 2.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2016081312438N21
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with type 2 diabetes mellitus
Aged 35–70 years

Exclusion Criteria

Mulberry extract intake in the last three months
Changing in glucose-lowering medications
Taking anticoagulants during the study
Pregnancy or lactating
Malignancies
Chronic hepatic diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HOMA-IR. Timepoint: Before the beginning of the study and 12 weeks after. Method of measurement: Calculated with HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath